THG Plc (THG) Earnings Call Transcript & Summary
March 26, 2026
Earnings Call Speaker Segments
Matthew Moulding
executiveGood morning, everyone, and thanks for being with us today for the presentation of our full year 2025 results. It's a pleasure to report on what has turned out to be a landmark year — our first as a consumer-focused group, and one filled with a great many important initiatives. We put up a strong full year 2025 performance that came in ahead of both our guidance and market consensus, with adjusted EBITDA of GBP 76.6 million, which sets a solid base for meaningful progress once again in the year ahead. On the balance sheet, we've deleveraged meaningfully. Our debt facilities now run out to the end of 2029, and we finished the year with over GBP 330 million in cash and available facilities, which gives us real financial flexibility going forward. At the start of the year, we completed the demerger of THG Ingenuity, and with that, THG became what it is today: a focused consumer-led group built around two leading businesses in their respective markets, THG Beauty and THG Nutrition. For the first time since COVID, both businesses delivered full year revenue growth in 2025, with nutrition delivering four consecutive quarters of growth in the year. The group's momentum in the second half was especially encouraging, with Q4 delivering our best performance of the year at 7% revenue growth.
Matthew Moulding
executiveFor THG Beauty, it was a record-setting year when it came to launching new brands, and we delivered an outstanding showing in our domestic markets — especially LOOKFANTASTIC U.K., where we gained share across both established and fast-growing segments. Over in THG Nutrition, our multi-model approach is producing meaningful gains in market share, and Myprotein posted revenue growth of nearly 10% in H2, even though the model changes across Asia and India initially pulled sales down in those regions. New partnerships, expanding offline and licensing channels, and diversification across categories are all helping build a revenue base that is more balanced and more resilient. We've also made substantial headway on our VAT claim, which now stands at roughly GBP 78 million after we applied prudent treatment to protein, collagen, and supplement products over the years, while some of our competitors zero-rated products. A resolution is expected later this year, and together with meaningful free cash flow generation, that could roughly halve net debt by year-end. Now to THG Beauty — a business that has undergone a significant overhaul of its business model in recent years, creating a strong and unique platform for growth in revenue and active customers. We had our biggest ever year for new brand launches on the platform. We are firmly the destination of choice for the world's leading beauty brands, and that was very evident in 2025.
Matthew Moulding
executiveThe Huda Beauty Lip Contour Stain was our largest new product launch ever — a fantastic exclusive that generated huge engagement and traffic. On top of that, our advent campaign during peak trading broke new records, and THG Beauty enjoyed its biggest year yet for exclusive launches, which matters enormously for standing out in a competitive market. THG Beauty also grew into the largest UK beauty retailer on TikTok Shop — a channel we consider strategically vital for connecting with the next generation of beauty shoppers. Turning to own brand, our biggest launch was the Biossance Eye Serum, which further bolsters our margin accretive brand portfolio; over the year we've invested in repackaging and reformulating those brands so they stay relevant and compelling within beauty regimes. Now to THG Nutrition and Myprotein in particular. Myprotein holds the number one sports nutrition position worldwide, with an enviable level of engagement across a fast-growing, evolving health and wellness demographic. That market leadership keeps getting stronger. Brand awareness reached record levels this year, with our highest ever unaided awareness score in the UK, where we are the clear market leader. Myprotein's aided awareness likewise hit a record high, further backing the success of the major rebrand carried out in 2025.
Matthew Moulding
executiveMore than half of our target demographic now knows the Myprotein logo, and that reflects both how large and how effective our marketing spend is, along with our multi-model approach. In offline and licensing expansion, Myprotein's progress has been outstanding, with all of over 43 million products now licensed and sold into global retail. Our Mars products launched this week, and that launch builds on the uniqueness and quality of the Myprotein brand, with the world's largest brands eager to partner with us and reach the Myprotein community. This channel remains early in its growth journey, and when you pair it with the broader B2B retail partnerships, it's clear why we're confident about the medium-term trajectory for this business despite the well-documented commodity price pressures. Beyond protein powders, activewear is a category to watch. It's a structurally attractive, margin accretive category, and our expectation is this will be delivering a run rate of GBP 100 million in sales within 12 to 18 months after delivering over GBP 50 million of revenues for the full year of 2025. Turning to the outlook. On the full year expectations, we are guiding towards mid-single-digit group revenue growth with gross profit margin improvements year-on-year, despite the current record high commodity pricing.
Matthew Moulding
executiveWe anticipate delivering meaningful EBITDA progression, driven not just by ongoing sales growth and margin improvement, but also by the advantage of substantial OpEx savings as headcount reductions annualize, while we keep generating fresh savings through the use of AI. Turning to each business, THG Beauty heads into 2026 with robust underlying growth, especially in the U.K. and U.S., our two largest markets. Following a slower start to the prior year, the U.S. is doing really well, and our pipeline of new brands and products stays very healthy. In nutrition, we see strong progress across channels, with clear actions underway to enhance mix and profitability, alongside a defined strategy for managing whey price volatility via procurement, diversification, and disciplined pricing. Once commodity pricing begins to decline from record highs, hopefully before the end of the year, we then expect a marked impact on profitability growth beyond 2026. On cash, we expect free cash flow of GBP 25 million-GBP 50 million, with CapEx broadly flat year-over-year, working capital inflows following last year's temporary investment in stock, and a reduction in financing costs. Our results show our continued progress against our strategic vision of becoming the leading destination for prestige beauty and sports nutrition.
Matthew Moulding
executiveThat connection linking our strategy with how we execute is what supports the robust momentum we brought into 2026 across end markets that are fundamentally strong. The team is sitting here alongside me right now, and at this point we would be glad to field a few questions, and thank you again for all of your support.
Operator
operatorThanks a lot, sir. Ladies and gentlemen, should you wish to pose a question by audio, kindly hit star one on your telephone's keypad. And please make sure your line stays unmuted until the signal gets through to our equipment. That's star one to ask questions. This morning's opening question comes from John Stevenson at Peel Hunt. Go ahead, please. Your line is open, John.
John Stevenson
analystMorning, everyone. I have two or three questions, though I’ll try to hold myself to two. I think I’ll begin with the VAT claim. On that VAT claim, right now you’re still treating sales as standard rate and paying that amount over to HMRC. Then, second, assuming HMRC confirms that protein powders will be zero-rated, do you think that leads to lower prices for consumers? My second question concerns nutrition’s margin recovery prospects this year. There are clearly a lot of moving parts. You know, apparel is growing strongly. We have offline licensing on whey sales. Could you talk through the drivers and how you expect things to play out this year? Maybe, finally, I’ll add the last one: obviously, you sold Claremont last year. What are your thoughts on the potential for further sales of non-core assets? I guess what do you consider non-core?
Matthew Moulding
executiveTurning to where things stand on the VAT claim more broadly, I think we have a number of claims lodged with the Revenue totaling roughly GBP 78 million. Yes, that's exactly right. The Revenue has lost its appeals on the vast majority of the items involved. For several years, competitors have been taking that approach. Naturally, we adopted a very prudent stance, continuing to pay VAT monies over to HMRC while monitoring the situation closely. Now, regarding how VAT is treated, clearly we will be changing that treatment this year. It's probably an ideal moment to make that change as well, really, because whey pricing is not only at record highs, it's at explosive highs, since a number of market forces have caused what is almost a tulip moment in the commodity. Naturally, we're in a really strong position to absorb that compared with our competition, particularly now that we have the benefit of zero-rated VAT to apply. As for what that means for consumers, I think over time, naturally, consumers will see some benefit. Given that THG has already been operating by subsidizing the products, while our competitors have zero-rated, or some of them have, as a result we've already taken that competitive position.
Matthew Moulding
executiveWe'd anticipate meaningful margin gains from two big tailwinds: whey prices coming down and the VAT treatment. Those are two substantial tailwinds we're eager to unlock while whey pricing remains where it is today. The real benefit probably won't show up for a number of months, but we're looking forward to it coming through. On your question about margin progression at Myprotein, naturally there are plenty of opportunities ahead that set up a very strong margin recovery, not least whey pricing — but set that one aside. Then there's VAT, so we can set that one aside too. As we mentioned in the presentation, we sold 43 million products through licensing and offline into global retail last year, which is bigger than any other nutrition brand's total product sales, globally. That's just our licensing and offline business model. Now, the licensing part of that is pure profit, so that's great for margins. On the offline retail sales, we entered that market on a low margin basis, almost running that channel at break-even or slightly negative to slightly positive depending on the given period.
Matthew Moulding
executiveSo with a sizable install base now in place, we're going to keep growing it, since the opportunities we're seeing are fantastic. Of course, there will be a very strong stretch during which we can begin delivering meaningful gains in that margin stack as well. A few other things I mentioned, I believe, just in the opening intro there—you may have picked up on categories, new ones we've moved into, like activewear, which is genuinely accretive. To give you a sense of the trading margin there alone, the trading margin in that category has gone from 42% trading margin on a far smaller sales figure only a couple of years back to roughly 60% trading margin in that category right now, at a much larger scale. As categories like that one, creatine and other collagens, plus various other products we've launched, grow and turn into a bigger piece of the sales mix, we'll see meaningful margin progression across the Myprotein division. Things outside our control—say, sudden spikes in whey pricing—will of course create some near-term volatility now and then. We're highly confident that the underlying factors behind that volatility will fade, and the market will be far more normalized at some point in the not too distant future, or 12 months, 18 months at the very latest, since so much new supply is arriving, entering the market as well.
Matthew Moulding
executiveThe last question, I believe, concerned the other assets we hold. This group contains a lot of genuinely high-quality smaller businesses that receive limited attention from outside. We've received offers for several of them — notably, toward the end of last year, an approach came in for one of those divisions, one of those smaller businesses. It fell short of our valuation, which would have been a very substantial figure. We have no desire to part with assets — high-quality assets performing extremely well; even if the market doesn't necessarily see THG as centered on them, we recognize significant value there. Without a proper valuation, we won't sell them. Again, this year, other assets — different ones once more — have drawn meaningful interest toward us. Every single time, we're crystal clear, and we don't waste any time. We know what our assets are worth, as you saw with Claremont. If somebody is prepared to pay a proper price and it's the right move for the group, then obviously we would proceed. If we were to complete one of those this year, my expectation is that would bring us to net debt free, given the VAT point and the scale of value we'd be contemplating for one of those smaller businesses.
John Stevenson
analystAll right, excellent. Thanks a lot. Appreciate it, Matt. Cheers.
Operator
operatorAppreciate that question, sir. Everyone, I'll repeat: should you have any questions or follow-ups, kindly press star one now. We'll take a brief pause. One more question has just arrived, and it's from Grace Gilberg at Jefferies. Grace, the floor is yours.
Grace Gilberg
analystHi, everyone. Thank you for taking my call, or rather my questions. I have a few, if I may. The first one concerns nutrition. I mean, you did already address this somewhat in the previous question, but could you talk a bit more about some of the cross-selling opportunities within that division, and about how you would be able to consistently defend that segment, or within Myprotein, against some of the more specialized players out there? Whether that's around athleisure or other nutrition brands, that would be really helpful. Then the last two I have are also on beauty. Obviously beauty is another larger component of the group and is becoming more and more critical to the business. Can we speak a little bit more about the growth targets outside the U.K. and about how you are consistently defending the beauty proposition there outside the U.K.? My last one is probably a bit more general, but it would be helpful to understand a little bit more of the mix shift within beauty and how we're thinking about moving between makeup and skincare. Obviously, skincare had such a huge boom in the pandemic. We've seen that come back a little bit, but how do you think about your beauty businesses working between both of those segments?
Grace Gilberg
analystThat would be really helpful.
Matthew Moulding
executiveOkay. On nutrition — how does it hold up against the specialist competitors, and so on? One of the main points, I'd say, is that we have a substantial community, and that's true both on the consumer side and on the marketing side. Given how strong the brand is and how good the product quality is that we bring to market, if we execute properly, we can genuinely perform very well alongside the Myprotein community. That community's strength shows up when it comes to online retailers. If you ever talked to anyone who has brought Myprotein into a store, you'd see we have a major effect on the traffic that goes to offline retailers in particular product categories. I believe we've mentioned Iceland before — the Myprotein partnership there — and the fairly significant effect it had on their footfall and their customer demographic. Even at major retailers on the scale of Tesco's, you walk in and we are literally the sole player in the market able to bring together, in a big retailer like that, a single large branded bay that pulls multiple product categories together. And when you consider the Greencore Group proposition we've had, the number of people the brand draws to the lunchtime meal deal aisle in a retailer will shift dramatically, because there are Myprotein products sitting in there.
Matthew Moulding
executiveWhat this indicates is that the community we operate in feels strongly about the brand, there is trust in it, and provided we deliver genuine quality, we are able to introduce new areas into them. Even something like the partnership with Mars and so on demonstrates the extent of recognition across the broader industry regarding the strength of the brand we possess. If you consider the progress we have made in athleisure wear, since that is one you brought up, we have managed to raise margins by 50% in absolute terms on the product. We have been able to shift our price point considerably, and all of it has been underpinned by an extraordinary level of quality. Should you go and try the product, and so forth, you will find that the quality of the design, along with the marketing supporting it, is exceptional. The influencer community worldwide can connect with the Myprotein product at so many different levels in their lives that they are able to become genuine brand ambassadors instead of one day promoting a bit of Myprotein and the next competitor two, three, four and five, they can truly live the brand.
Matthew Moulding
executiveSo I believe beauty came up next. Did we move directly to beauty at that point?
Neil Mistry
executiveWhen it comes to beauty, our growth beyond the U.K.
Matthew Moulding
executiveYeah, Lucy is sitting right here with me. Actually, rather than have me field that one, you know, I ought to hand things over to Lucy. That area is her specialty.
Lucy Gorman
executiveCertainly. Thanks, and hi, Grace. Regarding where we're concentrating beyond the U.K., you'll recall that several years back we made the decision to leave certain other markets in which we had been operating. We exited Asia entirely, and in Europe we scaled back substantially and resized the business. We do still run a small operation in Europe today, but as for where our attention and capital are directed right now, it's entirely on the U.K. and the U.S., since we see ample headroom to achieve meaningful gains in both of those markets over the coming few years. In the U.S., performance is strong. We hold a fairly defensible proposition there, centered on high-value clinical skincare, which differs considerably from what players such as Ulta, Sephora, and Amazon provide. It's heavily regimen oriented, so our baskets are mixed, and there's substantial engagement with the consumer to help them determine which skincare regimen suits them. I believe your following question concerned category and the dynamics we're observing there. Across beauty, our category mix is actually reasonably broad.
Lucy Gorman
executiveIn our case, skin, hair, and makeup are each roughly the same size, and fragrance is the smallest for us — the opposite of what the overall beauty category shows. Over the past couple of years, we've managed to grow our fragrance portfolio ahead of the market, and that's produced a substantial amount of growth. We're actually seeing really healthy growth in cosmetics, and as you said, although skincare growth has tailed off since coming out of the pandemic, it's actually still been relatively strong for us. As for haircare, that category has seen a huge boom over the last couple of years. In fact, that's where LOOKFANTASTIC came from. At one point, LOOKFANTASTIC held around 80% market share in professional haircare online. Naturally, as some other players have come online into that category, that has diminished somewhat. For us, haircare is about defending our kind of stewardship and leadership in that category. We've actually seen fairly broad-brush positive growth across all of those categories over the last 12 months or so and into this year. You know, we don't see the skincare dropping off as a huge problem for us, albeit the trends within skincare are evolving every day.
Grace Gilberg
analystThat’s great. Thank you very much. I appreciate that.
Operator
operatorThanks, Grace. We’ll take our next question, which is a follow-up from John Stevenson at Peel Hunt. John, please go ahead.
John Stevenson
analystThanks. Appreciate it. Just two more from me. You've opened your second LOOKFANTASTIC store, I believe somewhere around Bristol. How's that performed? What has it meant for the online halo effect? And do you have any further openings planned this year? Then my second follow-up is on the licensing pipeline in nutrition, covering both existing partnerships and the potential for new ones — if you could say a little about what's coming this year.
Matthew Moulding
executiveHonestly, I think I should take this one on behalf of Lucy, since Lucy would be delighted to open, you know, 10 or 12 stores and commit some CapEx toward that. By the logic of it, we achieve a fairly quick payback on a number of these stores, correct? My view is that when we launch a store, the payback we get depends on the level of support received across different areas. You would be talking about a two-year payback when a store is opened. Clearly, offline is a tougher market in general over the longer term from a structural standpoint, but beauty is a category experiencing material growth. Because of that, we will be opening additional stores. You know, physical store openings will proceed at a steady, relatively slow pace. It will be solely our brand. Having said that, you know, there is in fact a growing possibility that we will enter into a partnership with other players under which we take over the operation of their stores and rebrand them into ours. That involves lower CapEx. They already have the traffic footfall. We contribute a great deal to the offering. Consequently, that is something we are actively exploring as well. Now, were we to do that, it would accelerate quite materially the number of stores we would have out there.
Matthew Moulding
executiveHonestly, each store we launch generally brings in roughly GBP 2 million in revenue. In the wider context of our beauty operation, which does GBP 1.2 billion to GBP 1.3 billion in revenue, that isn't huge, but what we genuinely get is real brand value and marketing value, among other things, from having a modest estate. We won't hurry to add 10 more over the coming 12 months, though progress will be steady.
John Stevenson
analystMoving on to nutrition and licensing.
Matthew Moulding
executiveYeah, sorry about that. So, Neil — here's the thing.
Neil Mistry
executiveYeah.
Matthew Moulding
executiveYou want to mention a couple of them — though, I mean, we can't name them, right?
Neil Mistry
executiveRight.
Matthew Moulding
executiveSo, just a few thoughts on how things are going with licensing.
Neil Mistry
executiveLooking at licensing, you're going to see us keep expanding what we're doing with Mars. As was already brought up, the Mars product launched this week, and it's off to a really strong start. You'll see additional pieces of the Mars partnership come together over the course of the year. More partnerships in the flavor profile space will keep appearing as well, and those will probably skew more toward the U.S. market. On the licensing-out side, you'll see Greencore roll out, plus additional expansion in the food to go area. And you'll see us move into new spaces such as ready-to-drink too.
Matthew Moulding
executiveAny-
John Stevenson
analystAlright, that’s great.
Matthew Moulding
executiveIs there anything else, John, now that we have you on the line?
John Stevenson
analystThanks, Matt. Oh, where should I begin?
Matthew Moulding
executiveI'll spare you having to check back in another 10 minutes.
John Stevenson
analystI could continue, but yeah, no, that's fine. I can still drop in, though. That works for the moment. Appreciate it, Matt.
Matthew Moulding
executiveOkay, thanks, John.
Operator
operatorThanks, John. Since there are no more questions right now, I'll hand the call back to Matthew Moulding for any additional remarks or closing comments.
Matthew Moulding
executiveAll right, well, thank you all. I want to give a big thanks to the entire team for pulling this off. It has been quite an eventful year. I really appreciate it, and I'm grateful for the backing of every shareholder and stakeholder. Best wishes to everyone.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete THG Plc transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to THG Plc earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in THG Plc or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.